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1. In t roduct ion  
Activation of the classical pathway of complement 
proceeds through the transient formation of a C3 con- 
vertase, abimolecular complex due to an interaction 
of fragments C4b and C2a from components C4 and 
C2 [ 1,2]. This C3 convertase is highly labile and retains 
only shortly its capacity for p roteolyzing C3. In [3,4] 
control factors were described which could destabilize 
the C3 convertase. A protein has been purified from 
human serum, which is able to bind to native C4b 
and termed C4-binding protein (C4bp); this protein 
is also able to inhibit the formation of the C3 con- 
vertase and to accelerate the decay of its catalytic 
activity [5,6]. This protein is probably similar to a 
macromolecular cofactor described in [7] and detailed 
in [8,9]. 
C4bp has been purified from mouse, guinea pig 
and human plasma [5,10,11]. Most of the techniques 
described are complex and time-consuming. This paper 
describes a simplified method for the purification of 
C4bp from human plasma, to give the major charac- 
teristics of the purified protein and to demonstrate 
one of its interactions with native C4b. 
2. Materials and methods 
Human citrated plasma was obtained from the 
Abbreviations: SDS-PAGE, sodium dodecyl sulphate-poly- 
acrylamide gel electrophoresis; EDTA, ethylene diamine tetra- 
acetic acid; DFP, di-isopropylphosphorofluoridate; PEG, poly- 
ethylene glycol; STI, soybean trypsin inhibitor; EA, erythro-
cyte-bearing specific antibodies; IgM, immunoglobulins M 
Nomenclature: The nomenclature of the components ofcom- 
plement is that recommended by World Health Organization 
(196 8); a bar indicates the activated state of a component. 
Centre de Transfusion Sanguine (Grenoble). Serum 
was prepared as in [12]. 
Yeast alcohol dehydrogenase, horse spleen apofer- 
ritin, beef liver catalase were obtained from Calbio- 
chem, di-isopropylphosphorofluoridate w s purchased 
from Sigma and ampholine were from Pharmacia. 
Sheep erythrocytes were obtained from Bio-Merieux. 
Hemolysin and antisera to human C3, C4 and cerul- 
oplasmin were from Behring. Antisera to human serum 
was purchased from ICL Scientific. Antisera to human 
IgM, C1 Inh, Clq, Clr, C]s, C2, C4bp were obtained 
in our laboratory. Antisera to human 131H, 1 llJs (C4bp) 
and lgM were generous gifts from Dr Fountaine (Rouen), 
Dr Chapuis (Lausanne) and Dr Nussenzweig (New 
York), respectively. Other chemicals were of analytical 
grade. 
C]s and C4 were purified as in [13,14]. Purified 
proteins were estimated either according to [15] or 
~1% = 9.5 for Cis [16] and from their A28o, using "~1 cm 
El% = 10 for C4 [17]. OtherA280 were determined 1 cm 
by weighing purified proteins lyophylised from solu- 
tion in 10 mM N-ethylmorpholine (pH 9.7). C4bp 
purification was evaluated from an arbitrary A28o f r 
~r ~q% = 10.0. C4bp was selectively total proteins ,,,,  1 cm 
estimated by radial immunodiffusion [18] using 1% 
agarose and 1% anti-C4bp rabbit serum. Double im- 
munodiffusion i  1% agarose according to [19] was 
used for identification of the proteins. 
Molecular mass was taken as 200 000 for C4 and 
for its chains as ~ = 87 500, ce' = 78 000, 13 --- 70 000, 
3' = 31 000, respectively [14]. 
Sucrose gradient ul racentrifugation was as in [20]; 
runs were at 32 000 rev./min, at 4°C, with a TST 54 
rotor in a Kontron TGA 50 ultracentrifuge; horse 
spleen apoferritin (17.6 S), beef liver catalase (11.4 S) 
and yeast alcohol dehydrogenase (7.6 S) were used as 
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markers and proteins were estimated in each fraction 
as in [15]. 
For isoelectric focusing, proteins were directly 
applied on polyacrylamide gels containing ampholine 
(pH 3.5 10) as in [21]; focusing was carried out for 
13 h at 25°C. Crossed immunoelectrophoresis wa  as 
in [22] and the 50% haemolysis time assay was accord- 
ing to [23]. 
Samples reduced with dithiothreitol or unreduced 
were prepared for SDS-PAGE as in [13]. Gels con- 
taining 4.5% (reduced samples) or 3.5% (unreduced 
samples) acrylamide were prepared after [24] and run 
at an intensity of 5 mA/gel during 5 h. Proteins were 
stained with Coomassie blue and sugars were visualized 
according to [25]. a,/3 and 7 chains of reduced C4 and 
a mixture ofmultimeric IgG [5] were used as reference 
for molecular mass estimation of reduced and unre- 
duced proteins, respectively. 
Antibodies to C4bp contaminants were raised in 
rabbits according to [26] with a fraction of contami- 
nants prepared from the DEAE-Sephadex A 25 eluate 
(chromatography step described in the C4bp purifica- 
tion) as follows: after concentration by ultrafiltration 
on PM 10, the eluate was applied to a colunm of 
Sepharose-C4b equilibrated in 10 mM Tris-HC1, 
25 mM NaC1, 5 mM EDTA (pH 7.4) at 4°C. The frac- 
tion not retained by the column and corresponding to
C4bp contaminants was concentrated by ultrafiltration 
on PM 10. 
Other antisera were raised in rabbit also according 
to [26]. Total immunoglobulins were purified from 
pooled rabbit serum by sodium sulfate precipitation 
and proteins were coupled to Sepharose 4B as in [27]. 
3. Results 
3.1. Purification of C4bp 
Unless otherwise stated, all operations were done 
at 4°C. 
3.1.1. Treatment of plasma by inhibitors 
Frozen citrated plasma (500 mt) was thawed, cen- 
trifuged at 19 000 X g for 15 rain and incubated for 
40 min at 20°C with 11 mM EDTA, 5 mM DFP, 3 mM 
iodoacetamide and 25/lg STI/ml. 
3.1.2. PEG extract 
PEG 4000 15% (w/v) in 50 mM phosphate buffer 
(pH 7.55) containing 50 mM NaCI, 15 mM EDTA and 
5 mM DFP was added drop-wise to the plasma under 
continuous tirring to a final concentration of 5%: 
after 20 min the medium was centrifuged for 15 rain 
at 9000 X g and the resulting pellet redissolved in 92 ml 
10 mM Tris HCI buffer (pH 8.6) with 75 mM NaCI, 
5 mM EDTA, 5 mM DFP for an incubation of 1 h 
under stirring. 
3.1.3. DEAE-Sephadex A 25 
After centrifugation of the PEG extract at 
27 000 X g for 15 rain, the supernatant was applied 
to a column of DEAE-Sephadex A 25 (3 × 25 cm) 
equilibrated in 10 mM Tris HC1 buffer (pH 8.6) with 
75 mM NaCI, 5 mM EDTA, at a flow rate of 50 ml/h. 
The column was washed with the same buffer until 
the eluate A28o was <0.05. Protein elution was carried 
out with a linear gradient of 75-300 mM NaCI in 
5 mM EDTA, 10 mM Tris HCI (pH 8.6) (total vol. 
700 ml), 4 ml fractions were collected. C4bp and C4 
were detected in the eluate by double inmmnodiffusion 
and fractions containing C4bp free of C4 were pooled, 
corresponding to a conductivity of 6.7 mS measured 
at O°C. 
3.1.4. Affinity chromatography on Sepharose-bound 
anticontaminants 
The DEAE-Sephadex A 25 pool contained several 
proteins. The major contaminants, identified as IgM, 
were not separated from C4bp by molecular sieve 
chromatography (even at high ionic strength, acid pH 
or in 4 M urea), ion-exchange chromatography, 
Sepharose-con A or Sepharose heparin chromatog- 
raphy. The only successful method was a reverse im- 
mune-affinity chroinatography on a colunm of 
Sepharose 4B-linked antibodies to C4bp contaminants. 
After addition of DFP (5 mM final con 3, the DEAE- 
Sephadex pool was dialyzed against 20 mM Natl2PO4, 
0.5 M NaC1, 0.1 M glycme, 5 mM DFP (pH 9.0) and 
applied at a flow rate of 20 ml/h to a column of 
Sepharose 4B-bound antibodies to C4bp contaminants 
equilibrated in the same buffer. Fractions of 4 ml were 
collected. This step led to the specific fixation of a 
majority of contaminants by the immune-afl'inity anti- 
bodies and the non-specific fixation of C4bp on the 
activated Sepharose. Only one protein perfused with 
an app. M r ~ 70 000 determined by SDS--PAGE in 
reduced and u nreduced conditions;this unidentified 
protein was called '70 k protein'. The elufion was 
stopped when the A280 eluate was <002 and the 
column was then put at 20°C for 2 h before elution 
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Fig.2. Immunoelectrophoresis of purified C4bp. Diffusion 
against anti human serum diluted to 1/2 (anti SH 1/2) or 
undiluted (anti SH) and against anti-human 1 l13s (anti-1 l13s). 
Immunoelectrophorcsis wa done as in section 2. 
Fig. 1. SDS-PAGE analysis of C4bp. Electrophoresis wa done 
as in section 2:15 ~g protein was appfied to each gel; (1) unre- 
duced C4bp on 3.5% acrylamide gel; (2) reduced and alkylated 
C4bp on 4.5% acrylamide g l. 
of C4bp by the same buffer. After concentration f 
the eluate by ultrafiltration PM 10, ~10 mg C4bp 
were obtained: its purity was--~98%, from evaluation 
by SDS-PAGE. Controls by double immunodiffusion 
in agarose were negative with the following antisera 
to human IgM, 131H, C] Inh, Clq, C]r, C]s, C2, C3, 
C4. Immunoelectrophoresis in agarose showed only 
one precipitation line with undiluted antisera to human 
serum and a second fine line with the same antisera 
diluted to 1/2 (fig.2). 
A typical purification run is presented in table 1. 
3.2. Characteristics of purified C4bp 
C4bp was found to have app.M r ~ 800 000 as deter- 
mined by gel filtration; the purified protein exhibited 
two bands on SDS PAGE under non-reducing condi- 
tions (fig. 1) of app. M r 660 000 and 590 000. The 
proportion of the two bands, calculated from gel scan- 
ning, was 83% for the high form and 17% for the low 
form; except for the molecular mass, no difference 
between the two forms of C4bp could be observed: 
their ratio was not modified by heating (14 h at 37°C) 
or freezing and thawing or during the purification. 
Both proteins gave a positive periodic acid Schiff 
reaction, with an intensity corresponding to a similar 
proportion of carbohydrates. After r duction, a single 
band of app. M r 72 000 was observed. These results 
Table 1 
C4bp Purification 
Volume Protein a Total protein C4bp a Total C4bp Yield Purification 
(ml) (mg/ml) (mg) (mg/ml) (mg) (C4bp %) (-factor) 
Citrated plasma 500.0 58.00 29 000.0 0.226 113.0 100.0 1.0 
PEG-precipitate 98.0 29.20 2862.0 0.850 83.3 73.7 7.5 
DEAE-eluate 120.0 0.57 68.4 0.246 29.5 26.1 110.7 
Affinity column 
eluate after 
concentration 10.8 0.87 9.4 0.850 9.2 8.1 251.2 
a Total protein and C4bp wcre determined as in section 2 
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Fig.3. Solubility of C4bp at different pH-values: 100 #1 
50 mM Tris-HC1, 0.1 M glycine buffer, adjusted at different 
pH-values were added to 50 ul C4bp (50 ~g) in 10 mM Tris- 
HC1, 25 mM NaC1 and 5 mM EDTA (pH 7.4). The resulting 
pH-value was measured on each mixture; conductivity was 
6 mS at 0°C. After incubation of 2 h at 20°C followed by 
centrifugation (6 rain at 9000 × g), proteins were estimated 
in the supernatant according to [ 15 ]. 
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Fig.4.50% liaemolysis time assay. Sheep erythrocytes 
(10 9 cells/ml) in 2.5% glucose, 5 mM veronal, 142 mM Nat1, 
0.05% gelatine, 0.5 mM MgCI 2 and 0.15 mM CaCl~ (pH 7.5) 
were sensitized with rabbit antiserum to sheep red cells: 
3 ml EA diluted to 4 × 106 cells/ml were pre-incubated 
5 min in a spectrophotometer c llthermostatted at 30°C; 
20 ,,1 serum were injected in the cell suspension, immediately 
followed by addition of 100 #1C4bp or 70 k protein con- 
dning from 0 80 #g protein in 20 mM NaH=PO4, 0.5 M 
iaCl, 0.1 M glycine (pH 9.0). After rapid mixing, the absor- 
ance was monitored at 660 nm. 
suggest hat  C4bp is a po lymer  of  identical polypep- 
tide chains l inked by several disulfide bonds.  
Sed imentat ion  coeff ic ient measured by sucrose 
density gradient u l t racentr i fugat ion was 11.2 S for 
puri f ied C4bp and was not  modi f ied by freezing and 
thawing. 
Two isoelectric points were observed by electrofo- 
cusing of  C4bp on polyacry lamide gels: pH 5.6 and 
pH 5.9. A l though the pH 5.9 foml  was predominant ,  
it is not  yet possible to assimilate the two isoelectric 
values to the high and the low fract ion of  C4bp 
described above. These data were conf i rmed by two 
other  exper iments:  
- The solubil ity of  C4bp at di f ferent pH (fig.3) showed 
a min imum at pH 5.9, which ref lected a probable 
isoelectric precipitat ion.  
Migration of  purif ied C4bp on immunoe lect ropho-  
resis was anodal at pH 8.7 and cathodal  at pH 5.2, 
there was no appreciable migrat ion at pH 6.0. 
• ,1% = 9.3 and~l% A28o ° t /Z l  cm *~1 cm = 5.1 were obtained as 
in sect ion 2 for C4bp and the 70 k prote in,  respectively, 
in favour o f  a sharp dif ference of  structure between 
the two proteins.  By radial immunodi f fus ion  and using 
the above A28o, a level of  ~250 mg/1 was calculated for 
human plasma C4bp. 
Fig.5. SDS PAGE analysis, in reduced conditions, ofa C4b- 
C4bp link: 7.7 ug C4bp were mixed with 82 ~g C4 and 4/sg 
C]s in a total volume of 200 ul of 10 mM Tris-HCl, 0.15 M 
NaC1, 5 mM EDTA (pH 7.4). After a 30 rain incubation at 
37°C, an aliquot of 30 ul of the sample was reduced, alky- 
lated and applied to a 4.5% acrylamide gel. Electrophoresis 
was done as in section 2. Three controls were run in parallel 
including: (1) C4bp + Cis; (2) C4 alone; (3) C4 + Cis; (4) 
C4bp + C4 + Cls. 
52 
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3.3. Biological activity of C4bp 
C4bp biological activity was evaluated in a haem- 
olytic assay (50% haemolysis time (THso)). As shown 
in fig.4, EA mixed with a constant amount of serum 
were incubated with increasing amounts of C4bp: an 
increase of the THso from 8-12  rain was observed, 
with a plateau for higher concentrations of C4bp. 
A parallel assay, substituting the 70 k protein for 
C4bp, gave a similar decrease in haemolytic activity 
with a maximal THso-value plateauing at 11 min in 
this case. 
Further experiments with purified proteins con- 
firmed that C4bp is able to react with native C4b; 
SDS-PAGE analysis under reducing conditions of a 
mixture of C4bp, C4 and C] s showed a new protein 
band of app. M r 160 000, formed by the association 
of one unit of C4bp (72 000) and the a'-chain of C4b 
(78 000) (fig.5). 
4. Discussion 
The purification of C4bp raises several problems 
due to its affinity for IgM [9,28,29] and to an apparent 
polymorphism represented by a high and a low M r 
form [5,28]. We have consistently observed an associa- 
tion of a fraction of C4bp and IgM ; the bimolecular 
complex is very coherent (section 3). IgM contaminants 
could be eliminated only in the last stage of reverse 
immune affinity. Purified C4bp shows two different 
forms of app. M r 660 000 and 590 000, confirming 
the other results described. From the reported ata 
one may consider them as polymers differing only by 
one monomer, although recent data on the binding of 
a vitamin K-dependent protein S to C4bp suggest that 
C4bp in complex with protein S is identical to C4bp- 
high and that C4bp-low corresponds to uncomplexed 
C4bp [30]. As no biological function has yet been 
assigned to protein S which behaves on SDS-polyacryl-  
amide gel as a 70 k protein, more work is needed to 
clarify this point. An inhibitory role is detected by 
the haemolytic assay for the 70 k protein separated 
at the last stage of purification of C4bp; this result 
may question its analogy with protein S. Furthermore 
the absence of any precipitin line on double immuno- 
diffusion analysis between anti-C4bp and the 70 k 
protein as well as the difference between their A280 
leave this question open. 
C4bp is able to bind native C4b to form a covalent- 
like association which in some aspects may recall the 
ester or amide bond involved in the binding of C4b 
to membranes or immune complexes. This binding 
may account for one of the reactivities of C4bp, con- 
trolling or preventing the formation of the C~ con- 
vertase upon complement activation [5,31]. 
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